We are live on ! Find out more
DVAX

Dynavax Technologies

Delisted

DVAX was delisted on the 9th of February, 2026.

119 hedge funds and large institutions have $921M invested in Dynavax Technologies in 2017 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 48 increasing their positions, 27 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

165% more capital invested

Capital invested by funds: $348M → $921M (+$573M)

90% more call options, than puts

Call options by funds: $27.1M | Put options by funds: $14.2M

78% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 27

50% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 18

7% more funds holding

Funds holding: 111119 (+8)

2.17% less ownership

Funds ownership: 73.71%71.54% (-2.2%)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
119
Holders Change
+8
Holders Change %
+7.21%
% of All Funds
2.97%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
27
Increased
48
Reduced
27
Closed
18
Calls
$27.1M
Puts
$14.2M
Net Calls
+$12.8M
Net Calls Change
-$14.7M
Name Holding Trade Value Shares
Change
Change in
Stake
RPAM
26
Rhenman & Partners Asset Management
Sweden
$8.05M -$3.37M -212,793 -36%
PAM
27
Panagora Asset Management
Massachusetts
$7.77M -$4.89M -308,859 -46%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$7.73M +$1.72M +108,788 +43%
Invesco
29
Invesco
Georgia
$6.02M +$3.6M +227,666 +436%
GA
30
Glenhill Advisors
New York
$5.96M -$719K -45,458 -14%
FLAM
31
First Light Asset Management
Minnesota
$5.89M +$4.33M +273,930 New
CS
32
Candriam SCA
Luxembourg
$5.22M -$4.46M -282,000 -54%
EI
33
EAM Investors
California
$5.12M +$3.76M +237,938 New
ARTA
34
A.R.T. Advisors
New York
$5.1M +$3.75M +237,102 New
Charles Schwab
35
Charles Schwab
California
$5.06M +$857K +54,149 +30%
TCIM
36
TIAA CREF Investment Management
New York
$4.76M +$1.42M +89,570 +68%
CS
37
Credit Suisse
Switzerland
$4.61M +$2.65M +167,506 +357%
WMSA
38
Weiss Multi-Strategy Advisers
New York
$4.3M +$1.58M +100,000 +100%
Susquehanna International Group
39
Susquehanna International Group
Pennsylvania
$4.03M -$4.21M -265,822 -59%
RSCM
40
Rock Springs Capital Management
Maryland
$3.55M
Creative Planning
41
Creative Planning
Kansas
$3.26M +$73.1K +4,623 +3%
VIA
42
Vident Investment Advisory
Georgia
$3.23M +$72K +4,553 +3%
Bank of Nova Scotia
43
Bank of Nova Scotia
Ontario, Canada
$3.23M +$2.38M +150,177 New
AG
44
Artal Group
Luxembourg
$3.23M +$2.37M +150,000 New
Russell Investments Group
45
Russell Investments Group
United Kingdom
$3.02M -$230K -14,529 -9%
MWNA
46
Marshall Wace North America
New York
$2.93M +$2.11M +133,382 New
AllianceBernstein
47
AllianceBernstein
Tennessee
$2.82M +$1.02M +64,570 +97%
JMPWA
48
JP Morgan Private Wealth Advisors
California
$2.41M +$1.78M +112,260 New
UBS Group
49
UBS Group
Switzerland
$2.37M +$1.16M +73,029 +195%
GC
50
Guggenheim Capital
Illinois
$2.35M +$1.73M +109,039 New

DVAX Hedge Fund Activity: Q3 2017 in Review

119 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Dynavax Technologies (DVAX) for Q3 2017, worth a combined $921M — up 165% from $348M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new DVAX positions and 18 closed out — a net gain of 9 holders — while 48 added to existing stakes and 27 trimmed.

The largest buyer was State Street, adding an estimated $35.4M. The largest seller was William Blair & Company, exiting entirely with an estimated $17.7M sold.

  • 119 institutional investors held Dynavax Technologies (DVAX) as of Q3 2017, up from 111 in Q2 2017.
  • Funds reported $921M of Dynavax Technologies stock for Q3 2017, up 165% quarter-over-quarter.
  • 27 funds opened new Dynavax Technologies positions in Q3 2017 and 18 closed out, a net change of +9 holders.
  • The largest Dynavax Technologies buyer in Q3 2017 was State Street, an estimated $35.4M added.
  • The largest Dynavax Technologies seller in Q3 2017 was William Blair & Company, an estimated $17.7M sold.

Based on aggregated 13F filings for Q3 2017.